Difficulty: Medium
Average Score: 63%
Practice
A patient is prescribed raloxifene (Evista) for osteoporosis. What is the primary mechanism of action for this medication?
Correct answer
A
Rationale
Raloxifene (Evista) is a selective estrogen receptor modulator (SERM) used in the treatment of osteoporosis. The primary mechanism of action of raloxifene is to decrease bone resorption, which helps to maintain or increase bone density.
Option A is correct because raloxifene works by binding to estrogen receptors in the bone, mimicking the effects of estrogen. By doing so, it inhibits osteoclast activity, which reduces bone resorption and leads to a net increase in bone density.
Option B is incorrect because raloxifene does not directly affect calcium absorption in the intestines. Its main action is on bone tissue.
Option C is incorrect because raloxifene does not stimulate new bone formation by increasing osteoblast activity. Instead, it primarily inhibits bone resorption.
Option D is incorrect because raloxifene does not directly affect calcium excretion by the kidneys. Its main mechanism is related to bone turnover and density.
In an educational context, understanding the mechanism of action of medications used in osteoporosis is crucial for healthcare professionals to provide effective patient care. Knowing how raloxifene works allows for informed decision-making in prescribing and monitoring its effectiveness in managing osteoporosis.
Option A is correct because raloxifene works by binding to estrogen receptors in the bone, mimicking the effects of estrogen. By doing so, it inhibits osteoclast activity, which reduces bone resorption and leads to a net increase in bone density.
Option B is incorrect because raloxifene does not directly affect calcium absorption in the intestines. Its main action is on bone tissue.
Option C is incorrect because raloxifene does not stimulate new bone formation by increasing osteoblast activity. Instead, it primarily inhibits bone resorption.
Option D is incorrect because raloxifene does not directly affect calcium excretion by the kidneys. Its main mechanism is related to bone turnover and density.
In an educational context, understanding the mechanism of action of medications used in osteoporosis is crucial for healthcare professionals to provide effective patient care. Knowing how raloxifene works allows for informed decision-making in prescribing and monitoring its effectiveness in managing osteoporosis.